Disha Goyal is a dedicated healthcare professional with expertise in writing patient-friendly healthcare or clinical content. Disha is an experienced professional in offering comprehensive support to various healthcare projects. Disha uses extensive knowledge gained along with practical experience to achieve organizational goals. Disha has got experience in writing, editing, proofreading and producing brand promotion and patient awareness content (emailers, visual aids, detailers for doctors, newsletters).
Disha is also well-versed with offline annotations of scientific documents with proper referencing styles. Disha’s major areas of interest are in writing reports of descriptions about medicines of different therapeutic areas, editing presentations, training manuals, existing website content etc. Disha has also been a mentor to junior medical writers and guided them regarding how they can use their writing talent to their level best.
Education
- M.Pharma in Pharmacognosy at U.I.P.S., Panjab University, Chandigarh, 2013
- B.Pharma at U.I.P.S., Panjab University, Chandigarh, 2011
Experience
- August 2021 – Present, Content Writer at Breathe Well-being, Gurugram
- December 2020 - August 2021, Freelance Medical Content Writer at Emediscene, New Delhi
- July 2019 – September 2020, Freelance Medical Content Writer at TVB Healthcare Pvt. Ltd., New Delhi
- August 2018 – June 30, 2019, Full-Time Medical Content Executive at Delhi Nutraceuticals, Gurugram
- Since May 2016, Worked for an International/UK's No.1 Dissertation Writing Services named Projectdeals as a Freelance Medical Writer
- Jul 2016 - July 2018, Medical Content Head at Kunj Ayurveda, Spaze i-tech Park, Sohna Road, Gurugram
- August 2015 – May 2016, Medical Content Writer at Zatak Softech Pvt Ltd., Gurugram
- June 2014 – July 16, 2015, Medical Research Executive in Trial trove a product of Citeline at ADI Backoffice Professionals Pvt. Ltd., Mohali
Last updated on August 1st, 2022Breathe Well-Being becomes the first health tech company from India, with ADA (American Diabetes Association) recognition, reverses type 2 diabetes Overview of Breathe Well-being Online Diabetes Reversal Plan Breathe Well-being is the Gurgaon-based health-tech start-up. It was founded in 2020 by Mr. Rohan Verma and Mr. Aditya Kaicker. The company’s vision: …
Last updated on September 28th, 2022Osteomyelitis is an inflammation of bone tissue. This generally results due to an infection. Bone infection might happen due to many reasons. The condition may affect both children and adults. Infections can reach a bone by moving via blood or multiplying from adjacent tissue. Infections might also start in the bone …
Last updated on March 7th, 2022Glycomet GP2 Tablet is a medicine used to treat type 2 diabetes mellitus. It is a proven fact that diabetes can affect your overall well-being. When blood sugar is not managed properly it can result in a variety of health issues. The medicine comes to use here as it helps in …
Last updated on July 28th, 2023Tenglyn M 500 Tablet belongs to the class of drugs known as ‘antidiabetic agents,’ used to treat Type 2 diabetes. In diabetic patients who do not respond well to Metformin alone, this drug improves glycemic control. Diabetes mellitus type 2 is a long-term or chronic disorder in which blood sugar levels …
Last updated on March 2nd, 2022Glycomet GP 1 Tablet is a mixture of Glimepiride and Metformin, two anti-diabetic medicines. The sulfonylurea glimepiride works by raising the amount of insulin produced by the pancreas. Metformin, a ‘biguanide,’ works by decreasing glucose synthesis in the liver, slowing glucose absorption in the intestines, and enhancing the body’s insulin response. …
Last updated on July 20th, 2023NovoMix is a range of injectable suspensions marketed in cartridges (Penfill) or pre-filled pens (flexpen). NovoMix consist of the active substance insulin aspart (100 units per milliliter) in three forms: Novomix 30 contains 30% soluble insulin aspart (fast-acting) and 70% protamine crystals of insulin aspart (long-acting), The Novomix 50 contains 50% …